|Articles|February 20, 2008
L-acetylcarnitine Improves ADHD in Fragile X Syndrome
Treatment with L-acetylcarnitine may be beneficial in improving hyperactivity and social behavior in boys with fragile X syndrome who have attention-deficit/hyperactivity disorder (ADHD), according to an article published online Feb. 19 in the American Journal of Medical Genetics.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza
2
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
3
New sunscreen ingredient clears FDA for the first time since the 1990s
4
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
5